(EMAILWIRE.COM, November 16, 2018 ) The 3D cell culture market is expected to reach USD 1,720.3 Million by 2022 from USD 570.4 Million in 2016 growing at a CAGR of 20.3% during the forecast period. The base year considered for the study is 2016 and the forecast period is from 2017 to 2022.

Browse 111 Market Data Tables and 35 Figures spread through 140 Pages and in-depth TOC on "3D Cell Culture Market".

Download Free PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Based on applications, the cancer and stem cell research segment is projected to grow at the highest CAGR during the forecast period.

By applications, the 3D cell culture market is segmented into cancer and stem cell research, drug discovery and toxicology testing, and tissue engineering and regenerative medicine. The cancer and stem cell research segment is expected to register the highest CAGR during the forecast period. The increasing incidence of cancer and significant funding initiatives for cancer research from government as well as private organizations are supporting the growth of this application segment.

North America to dominate the 3D cell culture market

In 2017, North America is expected to dominate the market followed by Europe. The large share of this geographical segment is attributed to factors such as increasing incidence of cancer, presence of a well-established pharmaceutical and biotechnology industry, significant support from the government in the form of funds and grants, availability of technologically advanced products, and presence of key market players.

Request a Free Sample:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847